158429-58-4 Usage
General Description
3-(cyclopentyloxy)-4-methoxybenzamide is a chemical compound with the molecular formula C14H17NO3. It is a benzamide derivative, containing a benzene ring substituted with both a methoxy and a cyclopentyloxy group. 3-(CYCLOPENTYLOXY)-4-METHOXYBENZAMIDE has potential applications in medicinal chemistry due to its ability to modulate biological processes. Its structure suggests that it may have interactions with biological systems, particularly involving receptors or enzymes. Further research and testing are required to determine its specific biological activity and potential pharmacological uses.
Check Digit Verification of cas no
The CAS Registry Mumber 158429-58-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,4,2 and 9 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 158429-58:
(8*1)+(7*5)+(6*8)+(5*4)+(4*2)+(3*9)+(2*5)+(1*8)=164
164 % 10 = 4
So 158429-58-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H17NO3/c1-16-11-7-6-9(13(14)15)8-12(11)17-10-4-2-3-5-10/h6-8,10H,2-5H2,1H3,(H2,14,15)
158429-58-4Relevant articles and documents
COMPOUNDS CONTAINING PHENYL LINKED TO ARYL OR HETEROARYL BY AN ALIPHATIC- OR HETEROATOM-CONTAINING LINKING GROUP
-
, (2008/06/13)
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group
-
, (2008/06/13)
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.
